Vol.

No.

July 10, 2020Jul 10, 2020

DOWNLOAD THE PDF

$5.275 billion for NIH is a healthy chunk of change—but read the fine print

Cover Story

COVID-19 & Cancer

$5.275 billion for NIH is a healthy chunk of change—but read the fine print

By Paul Goldberg

A House subcommittee July 7 marked up a spending bill that proposes a $5.275 billion increase for NIH.

USPSTF broadens age range, risk threshold in new recommendation for lung cancer screening

By Matthew Bin Han Ong

Conversation with The Cancer Letter

USPSTF's Michael Barry: Recommendation on lung cancer screening aims to reduce mortality

By Matthew Bin Han Ong

Conversation with The Cancer Letter COVID-19 & Cancer Free

Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio

By Paul Goldberg

COVID-19 Updates

Yale researchers identify COVID-19 blood clotting cause

In Brief

Theoret, Beaver, Kim, Amiri-Kordestani named to new positions at FDA

Müschen named director of Center of Molecular and Cellular Oncology at Yale

Friedman named associate director for community science and health outcomes at Vanderbilt

Mehnert joins NYU Langone as associate director, clinical research

Yale researchers awarded $2.8M NCI Cancer Systems Immunology grant

Thermo Fisher and Chugai sign companion diagnostic agreement

Funding Opportunities

DoD Pancreatic Cancer Research Program funding opportunities for FY20

Defense Health Program DoD Rare Cancers Research Program anticipated funding opportunities for FY20

Clinical Roundup

Drug screens and CRISPR combine to make better cancer drugs, collaboration of researchers say

Fasting Mimicking Diets may enhance effectiveness of chemotherapy in cancer patients

Drugs & Targets

Inqovi approved by FDA for at-home MDS treatment

Keytruda's sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma

Lynparza approved in EU for germline BRCA-mutated metastatic pancreatic cancer

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 32 - September 05, 2025